We're excited to welcome you to the new Imanislife.com! Stay with us as we update and improve our site. We're glad you're here!

Imanis Life Sciences

Menu

Latest News

Stay up to date on the latest....

Imanis Volunteers at Ronald McDonald House

August 15, 2017

On August 13, the Imanis team had the pleasure of preparing dinner at the Rochester Ronald McDonald House. Since 1974, Ronald McDonald House has been dedicated to creating and supporting programs that directly improve the well-being of children and their families. We were happy to give a small amount of our time to the organization […]

Continue Reading

Dr. Freek Beekman Visits Imanis!

June 20, 2017

Imanis is excited to release a new video series showcasing our connections with leaders in the field of preclinical in vivo imaging, starting with Dr. Freek Beekman! We welcomed Dr. Freek Beekman to our offices on June 7. He was visiting Rochester, MN from his home in the Netherlands to give a presentation at Mayo Clinic. While visiting at Imanis, we […]

Continue Reading

In Vivo Tumor Progression Studies: An Educational Webinar with Bruker and Imanis

June 15, 2017

On June 8, Dr. Kah-Whye Peng, COO of Imanis Life Sciences, co-presented a webinar entitled “In Vivo Tumor Progression Imaging Studies” with Dr. Andrew Van Praagh, Bruker Biospin Field Applications Scientist. The webinar covered the benefits of multimodal reporter gene imaging and how it can be used to accelerate and improve preclinical research. Recent studies […]

Continue Reading

ASCO Update: Oncolytic virotherapy with immune modulators

March 21, 2017

Virotherapy in combination with immune modulators such as checkpoint inhibitors at ASCO-SITC. Presentation by Dr. Stephen Russell, Mayo Clinic.

Continue Reading

Imanis Life Sciences Launches Line of Oncolytic Vaccinia Viruses From Genelux Corporation

February 23, 2017

ROCHESTER, Minn., February 23, 2017 — Imanis Life Sciences announced today the launch of a new product line of oncolytic vaccinia viruses for virotherapy research. These viruses are licensed from Genelux Corporation as part of Genelux’s proprietary, vaccinia virus-based technology platform for research use. “We are excited to enter into a partnership with Genelux to offer […]

Continue Reading

NEW human NIS with enhanced TFB uptake for superior PET imaging of NIS in gene, cells and virus studies

November 16, 2016

Imanis is proud to announce the launch of a new line of NIS specifically tailored for PET imaging using the high sensitive tracer F18-tetrafluoroborate. This new NIS, NISplus, has been generated through mutagenesis and molecular modeling and has enhanced uptake of the PET tracer compared to wild type parental human NIS. It is now available […]

Continue Reading

NEW: Oncolytic recombinant herpes simplex virus 1 (HSV-1)

November 9, 2016

Imanis is pleased to announce the availability of three new recombinant HSV-1 viruses encoding reporter genes for use in in vitro and in vivo studies. These ready to use HSV-1 vectors encode the human sodium iodide symporter (hNIS), firefly luciferase (FLuc) or green fluorescent protein (GFP). These viruses have been thoroughly validated by our team […]

Continue Reading

NEW anti-NIS antibodies from Imanis Life

July 28, 2015

Imanis is proud to present our newly generated anti-NIS antibody. Applications tested include western blotting, immunofluorescence staining, immunohistochemical staining. Works on cryosections and paraffin embedded tissues. Recommended dilution: 1:2000 (the best out there!). BUY NOW!  

Continue Reading

Thank you for visiting us at the vendor show at Mayo Clinic Rochester

July 24, 2015

Imanis staff (Sam Russell and Chris Chen) explaining to scientists why NIS (the sodium iodide symporter) is the preferred reporter gene for in vivo imaging in small and large animals. (1) Non immunogenic, (2) High Resolution 3D imaging data, (3) Easy to use radiotracers (radioiodine or Tc-99m).

Continue Reading

First Midwest Preclinical Imaging Consortium Workshop

April 16, 2015

Imanis Life Sciences will be participating in the first Midwest Preclinical Imaging Consortium Workshop to be held on the campus of Mayo Clinic Rochester, April 19-20, 2015, Leighton Auditorium. This workshop is jointly organized by Mayo Clinic and Northwestern University, to encourage interactions and collaborative research between academic institutes and companies located in the Midwest. […]

Continue Reading

What people say about Imanis

Our group has, and continues to, use NIS as a noninvasive reporter for cell transplantation studies in mice and in pigs. Imanis has provided expert technical and analytical support for this research, and has allowed us to publish our research in high impact journals, including Science Translational Medicine..

– Dr. Raymond Hickey, Mayo Clinic

Learning Resources

Stay Informed

Stay up to date on the latest from the Imanis team, including product releases, promotional codes, and exciting new advancements in noninvasive in vivo imaging!